Archives of Clinical Infectious Diseases

Published by: Kowsar

The Risk of Nosocomial Infection with Multidrug-Resistant Corynebacterium urealyticum After Prostate Cancer Surgery

Zohre Baseri 1 , Mohammad Shayestehpour 2 , 3 , Yousef Erfani 4 , Arezoo Rasti 5 , Bizhan Romani 6 , 7 , Behrooz Mozaffari Namin 8 , Abbas Ahmadi Vasmehjani 9 , Kaveh Sadeghi 9 and Sajad Yaghoubi 10 , *
Authors Information
1 Department of Microbiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
2 Autoimmune Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran
3 Department of Microbiology and Immunology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran
4 Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
5 Oncopathology Research Centre, Iran University Medical Sciences, Tehran, Iran
6 Department of Biochemistry, University of Alberta, Edmonton, Alberta, T6G 2E1, Canada
7 Cellular and Molecular Research Center (CMRC), Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences (AJUMS), Ahvaz, Iran
8 Department of Microbiology of Pathobiology, School of Public Health, Tehran University of Medical Sciences, International Campus, Tehran, Iran
9 Virology Department, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
10 Department of Clinical Microbiology, Iranshahr University of Medical Sciences, Iranshahr, Iran
Article information
  • Archives of Clinical Infectious Diseases: April 30, 2019, 14 (2); e65327
  • Published Online: April 27, 2019
  • Article Type: Case Report
  • Received: December 19, 2017
  • Revised: September 4, 2018
  • Accepted: September 29, 2018
  • DOI: 10.5812/archcid.65327

To Cite: Baseri Z , Shayestehpour M, Erfani Y, Rasti A, Romani B , et al. The Risk of Nosocomial Infection with Multidrug-Resistant Corynebacterium urealyticum After Prostate Cancer Surgery, Arch Clin Infect Dis. 2019 ; 14(2):e65327. doi: 10.5812/archcid.65327.

Copyright © 2019, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
  • 1. Salem N, Salem L, Saber S, Ismail G, Bluth MH. Corynebacterium urealyticum: A comprehensive review of an understated organism. Infect Drug Resist. 2015;8:129-45. doi: 10.2147/IDR.S74795. [PubMed: 26056481]. [PubMed Central: PMC4445954].
  • 2. Chung CS, Liao CH, Cheng SL, Lin TH, Hsueh PR. Percutaneous nephrostomy tube-associated bacteremia caused by Corynebacterium urealyticum. J Microbiol Immunol Infect. 2008;41(6):525-7. [PubMed: 19255698].
  • 3. Soriano F, Huelves L, Naves P, Rodriguez-Cerrato V, del Prado G, Ruiz V, et al. In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum. J Antimicrob Chemother. 2009;63(2):353-6. doi: 10.1093/jac/dkn491. [PubMed: 19056748].
  • 4. Lopez-Medrano F, Garcia-Bravo M, Morales JM, Andres A, San Juan R, Lizasoain M, et al. Urinary tract infection due to Corynebacterium urealyticum in kidney transplant recipients: An underdiagnosed etiology for obstructive uropathy and graft dysfunction-results of a prospective cohort study. Clin Infect Dis. 2008;46(6):825-30. doi: 10.1086/528713. [PubMed: 18260786].
  • 5. Wood CA, Pepe R. Bacteremia in a patient with non-urinary-tract infection due to Corynebacterium urealyticum. Clin Infect Dis. 1994;19(2):367-8. [PubMed: 7986931].
  • 6. Soriano F, Tauch A. Microbiological and clinical features of Corynebacterium urealyticum: Urinary tract stones and genomics as the Rosetta Stone. Clin Microbiol Infect. 2008;14(7):632-43. doi: 10.1111/j.1469-0691.2008.02023.x. [PubMed: 18558935].
  • 7. Soriano F, Zapardiel J, Nieto E. Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents. Antimicrob Agents Chemother. 1995;39(1):208-14. [PubMed: 7695308]. [PubMed Central: PMC162510].
  • 8. Kiehlbauch JA, Hannett GE, Salfinger M, Archinal W, Monserrat C, Carlyn C. Use of the National Committee for Clinical Laboratory Standards guidelines for disk diffusion susceptibility testing in New York state laboratories. J Clin Microbiol. 2000;38(9):3341-8. [PubMed: 10970381]. [PubMed Central: PMC87384].
  • 9. Munoz-Bellido JL, Munoz-Criado S, Garcia-Rodriguez JA. In-vitro activity of psychiatric drugs against Corynebacterium urealyticum (Corynebacterium group D2). J Antimicrob Chemother. 1996;37(5):1005-9. [PubMed: 8737151].
  • 10. Fernandez-Natal I, Guerra J, Alcoba M, Cachon F, Soriano F. Bacteremia caused by multiply resistant corynebacterium urealyticum: Six case reports and review. Eur J Clin Microbiol Infect Dis. 2001;20(7):514-7. [PubMed: 11561814].
  • 11. Mohammad Nejad A, Shayestehpour M, Romani B, Mozaffari Namin B, Ahmadi Vasmehjani A, Yaghoubi S. A rare case of pneumococcal and meningococcal mixed meningitis in an infant with cardiac dysfunction. Arch Clin Infect Dis. 2018;13(6). e65270.
  • 12. Beiranvand M, Amin M, Hashemi-Shahraki A, Romani B, Yaghoubi S, Sadeghi P. Antimicrobial activity of endophytic bacterial populations isolated from medical plants of Iran. Iran J Microbiol. 2017;9(1):11-18. [PubMed Central: PMC5533999].
  • 13. Saeidi Y, Pournajaf A, Gholami M, Hasannejad-Bibalan M, Yaghoubi S, Khodabandeh M. Determination of Helicobacter pylori virulence-associated genes in duodenal ulcer and gastric biopsies. Med J Islam Repub Iran. 2017;31(95). [PubMed Central: PMC6014795].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments